ENDRA Life Sciences
NDRA
14 hedge funds and large institutions have $7.75M invested in ENDRA Life Sciences in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
7% less capital invested
Capital invested by funds: $8.35M → $7.75M (-$597K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$1.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$315K |
| 3 |
BlackRock
New York
|
+$236K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$157K |
| 5 |
State Street
Boston,
Massachusetts
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$1.81M |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$169K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$130K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$47K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$130K | -1 | Closed |
|
27
Barclays
London,
United Kingdom
| – | -$1K | – | – |
|
|
CAAS
28
Capital Asset Advisory Services
Williamston,
Michigan
| – | -$26K | – | – |
|
|
SFI
29
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$32K | – | – |
|
NDRA Hedge Fund Activity: Q2 2021 in Review
14 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2021, worth a combined $7.75M — down 7.2% from $8.35M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NDRA positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was NewEdge Advisors, opening a new position worth an estimated $1.57M. The largest seller was Flagship Harbor Advisors, exiting entirely with an estimated $1.81M sold.
- 14 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2021, up from 12 in Q1 2021.
- Funds reported $7.75M of ENDRA Life Sciences stock for Q2 2021, down 7.2% quarter-over-quarter.
- 6 funds opened new ENDRA Life Sciences positions in Q2 2021 and 4 closed out, a net change of +2 holders.
- The largest ENDRA Life Sciences buyer in Q2 2021 was NewEdge Advisors, an estimated $1.57M added.
- The largest ENDRA Life Sciences seller in Q2 2021 was Flagship Harbor Advisors, an estimated $1.81M sold.
Based on aggregated 13F filings for Q2 2021.